Your browser doesn't support javascript.
loading
Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.
Joseph, Chitra; Al-Izzi, Sara; Alsaleem, Mansour; Kurozumi, Sasagu; Toss, Michael S; Arshad, Maariya; Goh, Fang Qin; Alshankyty, Ibraheem M; Aleskandarany, Mohammed A; Ali, Simak; Ellis, Ian O; Mongan, Nigel P; Green, Andrew R; Rakha, Emad A.
Afiliación
  • Joseph C; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Al-Izzi S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Alsaleem M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Kurozumi S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Toss MS; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Arshad M; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.
  • Goh FQ; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Alshankyty IM; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Aleskandarany MA; Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Ali S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Ellis IO; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.
  • Mongan NP; Faculty of Medicine, Department of Surgery & Cancer, Imperial College London, London, UK.
  • Green AR; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.
  • Rakha EA; Cancer Biology and Translational Research, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Br J Cancer ; 121(9): 776-785, 2019 10.
Article en En | MEDLINE | ID: mdl-31558802
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos / Receptor gamma X Retinoide Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos / Receptor gamma X Retinoide Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido